Page last updated: 2024-09-03

ak 2123 and Peritoneal Carcinomatosis

ak 2123 has been researched along with Peritoneal Carcinomatosis in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Devi, PU; Rao, BS1

Other Studies

1 other study(ies) available for ak 2123 and Peritoneal Carcinomatosis

ArticleYear
Multimodality treatment using AK-2123, hydralazine, radiation & hyperthermia on a transplantable mouse tumour.
    The Indian journal of medical research, 1996, Volume: 104

    Topics: Animals; Combined Modality Therapy; Female; Hydralazine; Hyperthermia, Induced; Mice; Mice, Inbred BALB C; Neoplasm Transplantation; Peritoneal Neoplasms; Radiation-Sensitizing Agents; Sarcoma, Experimental; Triazoles; Vasodilator Agents

1996